Summit Therapeutics (SMMT) Stock Price, Quote, News & History | Benzinga

Summit Therapeutics Inc (SMMT) Stock Price, Quote, News & History

SMMTNASDAQ

Trade with Public

Trade with Public

$17.54

0.130.75%

At close: May 29, 5:00 PM EST

$17.70

0.160.91%

After Hours: May 29, 7:46 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$17.87

Close

$17.54

Volume / Avg.

7.21M / 3.62M

Day Range

$17.36 - $18.51

52 Wk Range

13.83 - 30.98

Market Cap

$13.74B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

22.12%

Days to Cover

6.3

Recent Summit Therapeutics Inc News

Dow Jones Hits Record Highs, DELL Jumps 15%: Stock Market Today

Dell, Qualcomm and HP power an AI-fueled rally to send the Dow to record highs. Nasdaq 100 and S&P 500 eyes eighth straight week of gains.

Piero Cingari

Roblox, Spotify, And Robinhood Are Among Top 10 Large-Cap Losers Last Week (April 27-May 1): Are The Others In Your Portfolio?

A broad sell-off led by Roblox Corporation, Spotify Technology S.A., and Robinhood Markets, Inc. highlights earnings misses and weak guidance dragging large-cap laggards.

Nabaparna Bhattacharya

Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU

U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on Hormuz news and Trump set 25% EU auto tariffs.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-384.05M

Investing Cash Flow (TTM)

-334.66M

Financing Cash Flow (TTM)

613.65M

Free Cash Flow (TTM)

-384.53M

Capital Expenditure (TTM)

-480.00K

Net Change in Cash (TTM)

-105.06M

Analyst Trends and Forecast

2

Feb

0

0

0

0

Mar

1

Apr

1

2

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$13.04B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

24.75

Earnings Yield % (TTM)

-9.16%

Earnings Yield % (FWD)

-6.01%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.70

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$106.52M

Debt to Equity

0.04

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$17.87

Close

$17.54

Volume / Avg.

7.21M / 3.62M

Day Range

$17.36 - $18.51

52 Wk Range

13.83 - 30.98

Market Cap

$13.74B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

22.12%

Days to Cover

6.3

About

Sector

Health Care

Industry

Biotechnology

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazo...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Summit Therapeutics (SMMT) stock?

A

You can purchase shares of Summit Therapeutics (NASDAQ:SMMT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Summit Therapeutics (SMMT) competitors?

A

There are no as such competitors for Summit Therapeutics.

Q

What is the forecast, or price target, for Summit Therapeutics (SMMT) stock?

A

Summit Therapeutics has a consensus price target of $32.13.

Q

What is the current price for Summit Therapeutics (SMMT)?

A

The stock price for Summit Therapeutics (NASDAQ: SMMT) is $17.7 last updated May 29, 2026 at 7:46 PM EDT.

Q

Does Summit Therapeutics (SMMT) pay a dividend?

A

There are no upcoming dividends for Summit Therapeutics.

Q

When is Summit Therapeutics (NASDAQ:SMMT) reporting earnings?

A

Summit Therapeutics does not have any upcoming earnings scheduled.

Q

Is Summit Therapeutics (SMMT) going to split?

A

There is no upcoming split for Summit Therapeutics.

Q

What sector and industry does Summit Therapeutics (SMMT) operate in?

A

Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.